These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 26343366)

  • 1. Targeting splenic hematopoietic stem cells in cardiovascular disease.
    Nahrendorf M; Dutta P
    Oncotarget; 2015 Aug; 6(24):19918-9. PubMed ID: 26343366
    [No Abstract]   [Full Text] [Related]  

  • 2. [Circulating endothelial stem cells: a new cardiovascular marker?].
    Hansen PR
    Ugeskr Laeger; 2004 Aug; 166(33):2815. PubMed ID: 15344866
    [No Abstract]   [Full Text] [Related]  

  • 3. Macrophages in Cardiovascular Homeostasis and Disease.
    Cao DJ
    Circulation; 2018 Nov; 138(22):2452-2455. PubMed ID: 30571351
    [No Abstract]   [Full Text] [Related]  

  • 4. Circulating proangiogenic cell activity is associated with cardiovascular disease risk.
    Mavromatis K; Aznaouridis K; Al Mheid I; Veledar E; Dhawan S; Murrow JR; Forghani Z; Sutcliffe DJ; Ghasemzadeh N; Alexander RW; Taylor WR; Quyyumi AA
    J Biomol Screen; 2012 Oct; 17(9):1163-70. PubMed ID: 22885731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the haematopoietic stem cells in primary myelofibrosis--in vitro colony forming capacity of the peripheral blood, the spleen, the splenic arterial and venous blood (author's transl)].
    Yamaguchi A; Yoshida K; Fukuda M; Fukushima Y; Sano M; Shibata A
    Rinsho Ketsueki; 1978 Mar; 19(3):221-5. PubMed ID: 702808
    [No Abstract]   [Full Text] [Related]  

  • 6. The correlation of hematopoietic stem cells with cancer stem cells through the regulation of stromal cells in tumor microenvironment.
    Lin S; Fu S
    Med Hypotheses; 2013 Apr; 80(4):494-7. PubMed ID: 23317540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trafficking of murine hematopoietic stem and progenitor cells in health and vascular disease.
    Schulz C; Von Andrian UH; Massberg S
    Microcirculation; 2009 Aug; 16(6):497-507. PubMed ID: 19479622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis.
    Sata M; Saiura A; Kunisato A; Tojo A; Okada S; Tokuhisa T; Hirai H; Makuuchi M; Hirata Y; Nagai R
    Nat Med; 2002 Apr; 8(4):403-9. PubMed ID: 11927948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Abnormalities of hematopoietic stem cells in autoimmune diseases].
    Qiu Z; Yu J
    Zhonghua Nei Ke Za Zhi; 1997 May; 36(5):352-4. PubMed ID: 10374277
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypothesis: myeloid-restricted hematopoietic stem cells with self-renewal capacity may be the transformation site in acute myeloid leukemia.
    Satoh C; Ogata K
    Leuk Res; 2006 Apr; 30(4):491-5. PubMed ID: 16183117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cell transplantation for cardiac and peripheral vascular disease.
    Burt R; Pearce W; Luo K; Oyama Y; Davidson C; Beohar N; Gheorghiade M
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S29-31. PubMed ID: 12931237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cell growth factor enhances multilineage hematopoietic recovery in vivo following radiation-induced aplasia.
    Patchen ML; Fischer R; Schmauder-Chock EA; Williams DE
    Exp Hematol; 1994 Jan; 22(1):31-9. PubMed ID: 7506673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enriched hematopoietic stem cells: basic biology and clinical utility.
    Szilvassy SJ; Hoffman R
    Biol Blood Marrow Transplant; 1995 Nov; 1(1):3-17. PubMed ID: 9118287
    [No Abstract]   [Full Text] [Related]  

  • 14. Hematopoietic progenitor cells in the blood and bone marrow in various hematologic disorders.
    Issaragrisil S; U-pratya Y; Yimyam M; Pakdeesuwan K; Khuhapinant A; Muangsup W; Pattanapanyasat K
    Stem Cells; 1998; 16 Suppl 1():123-8. PubMed ID: 11012154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic hematopoietic stem cells from sources other than bone marrow: biological and technical aspects.
    Bertolini F; de Vincentiis A; Lanata L; Lemoli RM; Maccario R; Majolino I; Ponchio L; Rondelli D; Tabilio A; Zanon P; Tura S
    Haematologica; 1997; 82(2):220-38. PubMed ID: 9175330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular MRI of hematopoietic stem-progenitor cells: in vivo monitoring of gene therapy and atherosclerosis.
    Qiu B; Yang X
    Nat Clin Pract Cardiovasc Med; 2008 Jul; 5(7):396-404. PubMed ID: 18477983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hematopoietic stem cells (CFU-S) in retrovirus-induced murine malignant histiocytosis].
    Eckmann L; Löhler J
    Verh Dtsch Ges Pathol; 1990; 74():120-5. PubMed ID: 1708568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cells in inflammatory disease.
    Rosen A; Casciola-Rosen L
    Curr Opin Rheumatol; 2006 Nov; 18(6):618-9. PubMed ID: 17053508
    [No Abstract]   [Full Text] [Related]  

  • 19. Mobilization of hematopoietic stem cells in a thalassemic mouse model: implications for human gene therapy of thalassemia.
    Yannaki E; Psatha N; Athanasiou E; Karponi G; Constantinou V; Papadopoulou A; Tasouli A; Kaloyannidis P; Batsis I; Arsenakis M; Anagnostopoulos A; Fassas A
    Hum Gene Ther; 2010 Mar; 21(3):299-310. PubMed ID: 19795976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependent abnormalities of hematopoietic stem cells in (NZW x BXSB)F1 mice.
    Sugihara A; Adachi Y; Inaba M; Hisha H; Sugiura K; Miyashima S; Amoh Y; Taketani S; Oyaizu H; Ikebukuro K; Kawamura M; Genba H; Horio T; Ikehara S
    Stem Cells; 1999; 17(6):357-65. PubMed ID: 10606164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.